• Student Slide

    Multidisciplinary program to train the next generation of biomedical scientists.

  • Title

    Probing the mysteries of human health and disease.

  • Title Slide 2

    Vibrant biomedical research campus situated in the beautiful Sonoran Desert Ecosystem.

  • Title Slide 3

    Collaborative research environment harnessing leading-edge technology and training.

A multidisciplinary PhD program focused on outstanding scholarship in the fields of immunobiology, molecular biophysics, and cell biology

Home Page

Over 50 Faculty and 30 PhD Students

The Cellular and Molecular Medicine (CMM) and Immunobiology (IMB) graduate programs at the University of Arizona have merged to create the Graduate Program in Molecular Medicine (GPMM). GPMM is an interdepartmental, multidisciplinary training program that fosters the development of scientists and educators who are prepared for lifelong participation in research and other intellectual pursuits. With an emphasis on bridging basic and translational science, Molecular Medicine trainees receive advanced training in the theory and practice of biomedical science. There are opportunities to investigate human health and disease ranging from biophysical studies at the atomic level, to modeling critical cellular process in tractable systems, to clinical research. The exposure and skills that our trainees acquire prepare them for careers in biomedical research (including academia and the biotechnology industry), science education, journalism, and public policy.

Cell Biology

Cell Biology

To provide students with a foundation for understanding the cellular underpinnings of human health and disease, while advancing the field through hands-on, cutting-edge research.

Medical Biophysics

Medical Biophysics

Apply quantitative multi-disciplinary approaches to molecular and integrative biology with a goal to understand the biophysical basis of health and disease mechanisms, identify drugable targets and contribute to Precision Medicine.

Immunobiology

Immunobiology

Advance the insights into the rules of engagement that determine the outcome of host-pathogen interactions to develop future therapies for infectious, autoimmune and malignant diseases.

News

Researchers discover new therapy that can reduce risk of breast cancer recurrance

Dr. Ghassan (Gus) Mouneimne, Associate Professor of Cellular and Molecular Medicine, is working with researchers at the Spanish National Cancer Research Centers to improve diagnostic tools and treatment for breast cancer. Click to read more.
Congratulations to Dr. Julie Ledford on Successful Renewal of her R01

Dr. Julie Ledford has been awarded $600,000 per year for the next four years - a successful renewal of her NIH/NHLBI R01 grant: "Defining mechanisms of CC16 on epithelial-driven host responses to pathogens." Congratulations to Dr. Ledford and her Co-Investigators Dr. Stefano Guerra, Dr. Joseph Vagner, and Dr. Darren Cusanovich.
CMM Welcomes Department Head Sakthivel Sadayappan, PhD, MBA

The Department of Cellular and Molecular Medicine is thrilled to announce the appointment of Dr. Sakthivel Sadayappan, PhD, MBA, as our new department head! Click to read more.
Dr. Curtis Thorne's Cancer Research is Personal

Curtis Thorne, PhD, brings a deeply personal perspective to his research, having battled cancer himself while his two brothers also faced their own fights with the disease. Click to read more.